Hologic Stock Current Valuation
| HO1 Stock | EUR 69.00 0.50 0.73% |
Valuation analysis of Hologic helps investors to measure Hologic's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Fairly Valued
Today
Please note that Hologic's price fluctuation is very steady at this time. Calculation of the real value of Hologic is based on 3 months time horizon. Increasing Hologic's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Hologic stock is determined by what a typical buyer is willing to pay for full or partial control of Hologic. Since Hologic is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Hologic Stock. However, Hologic's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 69.0 | Real 70.63 | Hype 69.0 |
The real value of Hologic Stock, also known as its intrinsic value, is the underlying worth of Hologic Company, which is reflected in its stock price. It is based on Hologic's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Hologic's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Hologic helps investors to forecast how Hologic stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Hologic more accurately as focusing exclusively on Hologic's fundamentals will not take into account other important factors: Hologic Company Current Valuation Analysis
Hologic's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Hologic Current Valuation | 18.25 B |
Most of Hologic's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Hologic is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Hologic has a Current Valuation of 18.25 B. This is 27.08% higher than that of the Healthcare sector and 99.63% higher than that of the Medical Instruments & Supplies industry. The current valuation for all Germany stocks is 9.8% lower than that of the firm.
Hologic Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Hologic's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Hologic could also be used in its relative valuation, which is a method of valuing Hologic by comparing valuation metrics of similar companies.Hologic is currently under evaluation in current valuation category among its peers.
Hologic Fundamentals
| Return On Equity | 0.21 | |||
| Return On Asset | 0.0858 | |||
| Profit Margin | 0.22 % | |||
| Operating Margin | 0.29 % | |||
| Current Valuation | 18.25 B | |||
| Shares Outstanding | 246.55 M | |||
| Shares Owned By Insiders | 0.73 % | |||
| Shares Owned By Institutions | 99.99 % | |||
| Price To Book | 3.70 X | |||
| Price To Sales | 3.52 X | |||
| Revenue | 4.86 B | |||
| Gross Profit | 3.31 B | |||
| EBITDA | 2.11 B | |||
| Net Income | 1.3 B | |||
| Cash And Equivalents | 601.8 M | |||
| Cash Per Share | 2.24 X | |||
| Total Debt | 2.81 B | |||
| Debt To Equity | 134.00 % | |||
| Current Ratio | 1.67 X | |||
| Book Value Per Share | 20.66 X | |||
| Cash Flow From Operations | 2.13 B | |||
| Earnings Per Share | 3.64 X | |||
| Price To Earnings To Growth | 0.91 X | |||
| Target Price | 85.5 | |||
| Number Of Employees | 6.94 K | |||
| Beta | 1.03 | |||
| Market Capitalization | 18.19 B | |||
| Total Asset | 9.07 B | |||
| Z Score | 3.6 | |||
| Net Asset | 9.07 B |
About Hologic Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Hologic's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Hologic using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Hologic based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in Hologic Stock
When determining whether Hologic offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Hologic's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Hologic Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Hologic Stock:Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Hologic. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. For more detail on how to invest in Hologic Stock please use our How to Invest in Hologic guide.You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.